Our columnist suggests how to think about stocks and bonds during a presidency that is signaling a deep devotion to profits.

Merck's blockbuster drug Keytruda and Eisai's cancer drug Lenvima, in combination with chemotherapy, failed to improve ...

While he has expressed support for North Carolina residents, the president has criticized California’s Democratic leaders and ...

He may have been only a virtual attendee, but the lines to see Donald J. Trump address the World Economic Forum stretched ...

A recent health news roundup explores legal, financial, and strategic developments. Highlights include Robert F. Kennedy ...

Trump then went on to criticize the nation’s electric grid, calling it old while noting that he would allow the tech companies to rely on any fuel that they want to run the plants. And if the energy ...

The latest health news includes Robert F. Kennedy Jr.'s nomination, Abbott's strategy amid global challenges, and Purdue Pharma's opioid settlement. It highlights company strategies, profits, and ...

Kennedy Jr.'s HHS nominee hearing with the U.S. Senate Finance Committee is set for Jan. 29. (FirstWord Pharma) Ahead of this ...

(Legal Fee Tracker is a weekly feature focused on attorney compensation. Please send tips or suggestions to ...

Department of Health and Human Services (HHS) secretary nominee Robert F. Kennedy Jr. plans to continue to receive referral fees from a law firm that is suing pharma powerhouse Merck & Co. | ...

The secretary of Health and Human Services nominee wrote in an ethics agreement that he would keep receiving contingency fees.

Robert F. Kennedy Jr. is openly vowing to make money off vaccine lawsuits if confirmed as the next HHS secretary.